MedTrace Logo

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

NCT02161965 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2019-11-07

No results posted yet for this study

Summary

The VICTORIA Study (Vascular CalcIfiCation and sTiffness induced by ORal antIcoAgulation) is a comparative, parallel, prospective, controlled and randomized study of the structural and functional impact of rivaroxaban versus anti-vitamin K drugs on the arterial vasculature.

Conditions

  • Permanent Atrial Fibrillation
  • Venous Thrombosis
  • Pulmonary Embolism
  • Anticoagulation Treatment at Least > or = to 12-month

Interventions

DRUG

Rivaroxaban

20mg or 15mg

DRUG

Fluindione

DRUG

Warfarin

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Georges LEFTHERIOTIS, MD, PhD · University hospital, Angers, FRANCE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-21
Primary Completion
2016-12-31
Completion
2018-02-16

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02161965 on ClinicalTrials.gov